Search
News Archive
Categories
03 2012
| Electronic Journal of Biotechnology Preparing Special Issue on Marine Biotechnology on September 15, 2012.
Call for Papers: invitation to submit a research article, review article, short communication or a technical note in the field of Marine Biotechnology or related areas. Submission Guidelines Original and unpublished contributions that are not currently under review by another journal are solicited. All manuscripts must be prepared in English and should be submitted through the online submission system available at http://www.ejbiotechnology.info/index.php/ejbiotechnology/about/submissions#onlineSubmissions |
03 2012
A new biodegradable material made from shrimp and crab shells that can replace petroleum-based plastics used in auto components helped a University of Toronto student win a national automotive competition. Aaron Guan, a master of science student, won the AUTO21 TestDRIVE competition, receiving a $10,000 scholarship for his work on recyclable, lightweight, polymeric nanocomposites.
Shrimp and crab shell fibres called chitin nanowhiskers form the base of this new material, which would allow automotive components to meet strict environmental standards without compromising vehicle safety. This material has a much higher strength-to-weight ratio compared to conventional plastics used in most automotive components, and provides higher mechanical strength without aesthetic flaws or deformation at lower densities.
Due to the composite nature of the material, mechanical properties can easily be engineered to suit various strength, stiffness and weight requirements simply by varying the combination of chitin nanowhisker and polymer content. The material is also completely renewable and sustainable as chitin nanowhiskers are derived from the waste of the fishing industry.
03 2012
Algae.Tec Ltd has announced that the AUD$5,000,000 (USD$5,354,086.97) Placement through Patersons Securities Limited has been successfully completed.
As previously stated, this capital raising will be utilised to fund the fast-tracking of commercial projects recently announced.
Algae.Tec Executive Chairman, Roger Stroud, said the Company was extremely pleased with the capital raising.
“This again demonstrates that sophisticated investors are aligned with the need for alternative transport fuel technologies such as the Algae.Tec enclosed algae to biofuels solution,” said Stroud.
“The market is also responding to the recent milestones and commercial deal announcements the Company has signed with major companies in China, Sri Lanka and Europe.”
31 2012
The company’s Western Australia operation in Karratha is planned to be increased from the initial 100 hectares of commercial operation to 400 hectares in the next stage, and then 1000 hectares.
Aurora Algae began operations in Karratha mid last year and now has its sights on raising $100 million after hitting the $22 million mark a few months ago.
The $22 million has left the company fully funded until its next expansion phase of harvesting algae-based biomass for products in the nutraceutical, pharmaceutical, aquaculture and renewable energy markets.
The company is looking to raise $100 million from existing and new private investors by mid-year, and is aligning at an IPO later in the year.
30 2012
Scottish company Aquapharm has joined forces with Norwegian firm Aqua Bio Technology (ABT) to create a new generation of sustainable ingredients for the skincare market.
Together the companies hope to identify natural marine ingredients that could replace the petroleum-based components used extensively within the skincare market.
Scientists at Aquapharm believe marine microbes are the key to finding the bio-active ingredients of the future, and have developed specialist fermentation processes to source and produce such extracts.
Now they will undertake a development program in conjunction with ABT, sharing their expertise in a bid to prove these extracts can be produced with minimal environmental impact – and successfully commercialized for the personal care market.
22 2012
A better understanding of how algae can be used to make biofuels is the aim of a new joint project between UC Davis and the University of Tokyo, Japan. It is one of four new grants, jointly funded by the US National Science Foundation and the Japan Science and Technology Agency, to develop environment-friendly fuels and reduce pesticide use.
The four grants, totaling $12 million (¥960 million), will be divided between the Japanese and US laboratories. UC Davis’ share will be about $1.5 million over three years, with the possibility of renewal for another two years.
All four projects are based on metabolomics, an approach that uses high-tech analysis to understand all the chemicals involved in a living cell’s metabolism.
22 2012
Good news on the algae-to-oil front has been released by Los Angeles-based OriginOil, Inc., in conjunction with the US Department of Energy. The company will work in partnership with Idaho National Laboratory (INL) to help algae growers to enter the global crude oil market.
OriginOil, a developer of a technology platform to extract oil from algae, reports that it plans to co-develop an integrated system with the DOE’s INL for direct conversion of raw algae into a renewable crude oil that can be used by existing petroleum refineries.
22 2012
Sapphire Energy Inc., which uses a proprietary process to turn algae oil into renewable gasoline to replace fossil fuels at the pump, broke ground last June on a 300-acre commercial demonstration facility in Columbus.
In Hobbs, in the heart of southeast New Mexico’s oil patch, Massachusetts-based Joule Unlimited Inc. broke ground this fall on a five-acre site that will use concentrating-solar biorefineries to extract ethanol and diesel from bacteria in salt-water mixed with carbon dioxide.
12 2012
Heliae, an Arizona-based algae technology company, announced today three significant additions to its expanding portfolio of intellectual property.
The United States Patent and Trademark Office issued patent number 8,084,038 to Heliae entitled “Methods of and Systems for Isolating Nutraceutical Products from Algae” on December 27, 2011. Heliae has received a Notice of Allowance from the USPTO for two additional patent applications focused on Heliae’s breakthrough extraction technology. These patents are expected to issue in the first half of February.
12 2012
ArcticZymes AS announced today the formation of ArcticZymes Inc. a wholly owned subsidiary located in Plymouth Meeting, PA. ArcticZymes AS is a subsidiary of Biotec Pharmacon, focusing on enzymes for use in molecular biology and diagnostics.
“The formation of a U.S. based subsidiary is a key milestone for our company and our B2B and OEM customers in North America. Our intention is to facilitate our end users’ research by providing access to our products and technical support in an effective and productive manner,” said Jan Buch Andersen, Managing Director of ArcticZymes AS.










